Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03364491 · ClinicalTrials.gov registry record · Phase 3
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 11,000
- Enrollment target
NCT03364491 is a Phase 3 study that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 11,000 participants.
The verdict
NCT03364491, a Phase 3 study, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 11,000 participants
- Enrollment target
Study Summary
A randomized placebo-controlled trial of 11,000 women to assess whether tranexamic acid as prophylaxis lowers the risk of postpartum hemorrhage in women undergoing a cesarean delivery.
Interventions
- DRUG Placebo
- DRUG Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,000 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2021-10-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03364491
The ClinicalTrials.gov registry entry for NCT03364491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 11,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03364491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03364491 about?
NCT03364491 is a clinical study titled "Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean". A randomized placebo-controlled trial of 11,000 women to assess whether tranexamic acid as prophylaxis lowers the risk of postpartum hemorrhage in women undergoing a cesarean delivery.
What is the current status of trial NCT03364491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 11,000 participants. The study started on 2018-03-15. Estimated completion is 2021-10-29.
What interventions are being tested in trial NCT03364491?
The interventions under investigation include: Placebo (DRUG), Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT03364491?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.